A searchable database of
medically documented cases

About the Project

Thyroid cancer

Thyroid Cancer

Epidemiology:

Thyroid cancer is increasingly recognized as a significant public health concern, given its rising incidence rate globally, particularly among women 1. Spontaneous remission (SR) in thyroid cancer, particularly in its differentiated forms, is an exceptionally rare phenomenon, reported in roughly 1 in 60,000 to 100,000 cases of cancer overall 2. While specific data on SR within thyroid carcinomas is limited, cases have been documented primarily in rare lymphomas associated with the thyroid, highlighting the sporadic nature of such events. The rarity of SR makes its study complex, as many instances go unreported unless the remission is notably marked and enduring; hence, assessing the true prevalence within thyroid malignancies poses a challenge 3.

Clinical Characteristics:

To date, there have been nine reported cases of spontaneous regression involving thyroid malignancies. Several clinical patterns can be observed among these cases. The patients’ ages at the time of regression ranged from 13 to 83 years, with a clear predominance in females. All reported cases involved the thyroid gland as the primary site, with remission occurring either within the thyroid itself or in regional lymph nodes. Proposed mechanisms included hemorrhagic necrosis, biopsy-induced immune response, and low-dose radiation exposure, although several cases did not report a specific cause. See Table 1 below for further information.

Histological Characteristics:

Of the cases analyzed, the histological types primarily included thyroid carcinomas, with one case involving primary thyroid lymphoma. Other thyroid lesions or benign nodular conditions were excluded from this data collection to maintain focus on malignant spontaneous regression cases.

Proposed Contributing Mechanisms:

Among the reported cases, the proposed mechanisms of spontaneous regression varied notably. In three patients, regression was associated with prior exposure to low-dose radiation, suggesting a possible radiation-induced immune or apoptotic response. One case attributed tumor regression to hemorrhagic necrosis within the thyroid tissue, while another implicated biopsy-induced immune activation as a triggering event. The remaining cases did not report a specific cause of regression. Collectively, these observations suggest that physical injury, radiation exposure, and immune stimulation may each contribute to the spontaneous regression of thyroid malignancies.

Site and Extent of Remission:

Among the reported cases, complete tumor regression was observed in nearly all patients, with remission occurring at both primary and metastatic sites. Most cases demonstrated regression of the primary thyroid lesion, while a few also showed resolution of metastatic involvement, particularly in regional lymph nodes. The duration of follow-up ranged from several months to over two decades, with some patients maintaining long-term remission for up to 21 years. Although follow-up data were not uniformly available, these reports suggest that spontaneous regression in thyroid malignancies can, in certain cases, result in durable disease control, distinguishing it from the more transient regressions observed in other cancer types.

Table 1: Thyroid Cancer SR Cases and Clinical Characteristics

Author–year

Age/sex

Primary site

Remission site

Proposed mechanisms

Follow-up

Yamamoto et al., 19784

24/F

Thyroid

Thyroid

Not reported

21 months

Maunand et al., 19805

13/F

Thyroid

Thyroid

Hemorrhagic necrosis

Not reported

Sasaki et al., 20166

69/F

Thyroid

Thyroid and lymph nodes

Low-dose radiation exposure

21 years

Sasaki et al., 20166

83/F

Thyroid

Thyroid

Low-dose radiation exposure

9 years

Sasaki et al., 20166

51/F

Thyroid

Thyroid

Low-dose radiation exposure

8 years

Shim et al., 20187

58/F

Thyroid

Lymph node

Not reported

9 years

Illán-Gambín et al., 20208

63/F

Thyroid

Thyroid

Biopsy-induced immune response

5 months

Vianello et al., 19809

Nodule

Evolution of AHTA towards regression

1 to 4 years

Bauman & Strawbridge et al., 198310

23.5/M

Thyroid gland

26 days

How et al., 819111

31/F

12 months, symptom-free

Sasaki et al., 198412

References:

  1. Heim E. , Köbele C. Spontaneous remission in cancer. Oncol Res Treat. 1995;18(5):388-392. doi:10.1159/000218627
  2. Chida K., Nakanishi K., Shomura H., et al. Spontaneous regression of transverse colon cancer: a case report. surg case rep. 2017;3(1). doi:10.1186/s40792-017-0341-z
  3. Silva G., Freitas V., Werkema F., Andrade J., & Silveira R. Spontaneous remission of primary papillary thyroid carcinoma: case report. Arch. Head Neck Surg.. 2021;50:e202150124. doi:10.4322/ahns.2021.0008
  4. Yamamoto T, Sakamoto H. Spontaneous remission from primary hypothyroidism. Ann Intern Med. 1978;88(6):808-809.
  5. How J, Khir ASM, Bewsher PD. Spontaneous remission of hypothyroidism due to Hashimoto’s thyroiditis. Lancet. 1980;2(8191):427.
  6. Spontaneous Disappearance of an Atypical Hürthle Cell Adenoma BAUMAN A; STRAWBRIDGE HTG American Journal of Clinical Pathology 80(3): Sep 1983; 399-402
  7. Sasaki J, Kurihara H, Nakano Y, Kotani K, Tame E, Sasaki A. Apparent spontaneous regression of malignant neoplasms after radiography: report of four cases. Int J Surg Case Rep. 2016;25:40–43. doi:10.1016/j.ijscr.2016.05.049
  8. Shim J, Rao J, Yu R. Spontaneous regression of metastatic papillary thyroid cancer in a lymph node. Case Rep Endocrinol. 2018;2018:5873897
  9. Vianello et al., 1980. Spontaneous Regression of Autonomous Nodules of the Thyroid: A Study of Eight Cases. Journal of Nuclear Medicine and Allied Sciences 24(1-2): Jan-Jun 1980; 63-71
  10. Bauman & Strawbridge, 1983. Spontaneous Disappearance of an Atypical Hürthle Cell Adenoma. American Journal of Clinical Pathology 80(3): Sep 1983; 399-402
  11. Lancet 2(8191): Aug 23 1980; 427
  12. Sasaki et al., 1984. Spontaneous Remission of Hypothyroidism in Hashimoto’s (Autoimmune) Thyroiditis. Israel Journal of Medical Sciences 20(7): July 1984; 625-629